Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × pamiparib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Neoplasms 4 Glioblastoma 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Rare Tumour 1 Neuroectodermal Tumors 1 Nervous System Diseases 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoadjuvant Therapy 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Locally Advanced Prostate Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hereditary leiomyomatosis and renal cell cancer 1 HER2-negative Breast Cancer 1 Gliosarcoma 1 Glioma 1 For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment 1 Central Nervous System Neoplasms 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1 Astrocytoma 1 Advanced Malignant Solid Neoplasm 1

Interventions

Temozolomide 134 Bevacizumab 62 Radiotherapy 58 Magnetic Resonance Spectroscopy 57 Irinotecan 25 Surgical Procedures, Operative 22 Carboplatin 22 Radiation 19 Specimen Handling 17 Carmustine 17 Aminolevulinic Acid 17 Blood Specimen Collection 16 Nivolumab 15 Biopsy 15 Lomustine 14 pembrolizumab 13 Radiotherapy, Intensity-Modulated 12 trametinib 11 Radiosurgery 11 X-Rays 10 Cyclophosphamide 10 fluorodopa F 18 9 Topotecan 9 IL13-PE38 9 Everolimus 9 ribociclib 8 dabrafenib 8 Surveys and Questionnaires 8 Imatinib Mesylate 8 Filgrastim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03749187 2026-03-13

PNOC017

University of California, San Francisco

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡